“…The dexamethasone intravitreal implant 0.7 mg (DEX implant, Ozurdex®, Allergan Inc., Irvine, CA, USA), a long-acting sustained-release corticosteroid [13], has been shown to be effective in treating DME [14-17]. Upon treatment with DEX implant, pro-permeability factors were reduced in aqueous samples [18].…”